NCT02693535 2026-03-19
TAPUR
American Society of Clinical Oncology
Phase 2 Recruiting
Clinical Trials
8,017 trialsNCT03853733 2026-03-19
Hypofractionated Palliative Radiotherapy in Patients With Advanced Non-operable Rectal Cancer
Consorci Sanitari de Terrassa
Recruiting
NCT04033497 2026-03-19
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
Brigham and Women's Hospital
Phase NA Recruiting
NCT04122313 2026-03-19
Post-contracture Release Radiation for Dupuytren's Disease
University of Minnesota
Recruiting
NCT04133077 2026-03-19
XenoBreast
Centre Jean Perrin
Phase NA Recruiting
NCT05065736 2026-03-19
Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer
Case Comprehensive Cancer Center
Phase EARLY_PHASE1 Recruiting
NCT05629845 2026-03-19
EUS-SPV
Chinese University of Hong Kong
Phase NA Recruiting
NCT06128343 2026-03-19
BACAP-2
University Hospital, Toulouse
Recruiting
NCT06184880 2026-03-19
APAORL2
Centre Hospitalier de Valence
Phase NA Recruiting
NCT06282588 2026-03-19
THUNDER
Cancer Research Antwerp
Phase 2/3 Recruiting
NCT06340945 2026-03-19
The Outcomes of Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules
Chinese PLA General Hospital
Phase NA Recruiting
NCT06359210 2026-03-19
SPAACES
Colorado State University
Phase NA Recruiting
NCT06379360 2026-03-19
Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients
The First Affiliated Hospital of Soochow University
Phase 2 Recruiting
NCT06475560 2026-03-19
DanCap
Odense University Hospital
Phase NA Recruiting
NCT06505122 2026-03-19
DLR RCT
University of Rochester
Phase NA Recruiting
NCT06962215 2026-03-19
IPSIMANON
University Hospital, Brest
Phase NA Recruiting
NCT07132190 2026-03-19
Stereotactic Radiation for Growing/Changing Brain Metastases With Same-Day Radiation Planning and Treatment With Margin Reduction
Brigham and Women's Hospital
Phase 2 Recruiting
NCT07172282 2026-03-19
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastases
Northwell Health
Phase EARLY_PHASE1 Recruiting
NCT07191730 2026-03-19
ML-CardioTox
University Hospital, Caen
Recruiting
NCT07227038 2026-03-19
Living Well With Advanced Breast Cancer
Ohio State University Comprehensive Cancer Center
Recruiting
NCT07238023 2026-03-19
Promoting Active Living Among People With Metastatic Breast Cancer
University of Oklahoma
Phase NA Recruiting
NCT07351669 2026-03-19
A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma
Zhongda Hospital
Recruiting
NCT07398677 2026-03-19
SchoolCare
Rigshospitalet, Denmark
Phase NA Recruiting
NCT07477886 2026-03-19
Ambient Sensing Room to Detect Early Signs of Adverse Events in Hospitalized Patients With Cancer
Mayo Clinic
Recruiting
NCT07481851 2026-03-19
Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients
Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
Recruiting
NCT02422641 2026-03-18
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT02468024 2026-03-18
STABLE-MATES
University of Texas Southwestern Medical Center
Phase 3 Recruiting
NCT03418038 2026-03-18
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia
Mayo Clinic
Phase 2 Recruiting
NCT03663725 2026-03-18
StrateGlio
Centre Oscar Lambret
Phase 3 Recruiting
NCT04038619 2026-03-18
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT04375384 2026-03-18
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
Wake Forest University Health Sciences
Phase 2 Recruiting
NCT04546945 2026-03-18
Aberrant Expression of CD56 in Patients With Hematologic Malignancies.
Assiut University
Recruiting
NCT04655404 2026-03-18
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Nationwide Children's Hospital
Phase EARLY_PHASE1 Recruiting
NCT04674267 2026-03-18
REACH
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT04895839 2026-03-18
PC-PEP
Nova Scotia Health Authority
Phase NA Recruiting
NCT05007379 2026-03-18
CARMA
Centre Oscar Lambret
Recruiting
NCT05020574 2026-03-18
Microbiome and Association With Implant Infections
University of California, San Francisco
Phase 2 Recruiting
NCT05092451 2026-03-18
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
Phase 1/2 Recruiting
NCT05187182 2026-03-18
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Washington University School of Medicine
Phase 1 Recruiting
NCT05223608 2026-03-18
ImmuCCo
Centre Oscar Lambret
Phase NA Recruiting
NCT05272826 2026-03-18
BOREALIS
Canadian Myeloma Research Group
Phase 2 Recruiting
NCT05384821 2026-03-18
MetroWilms
Centre Oscar Lambret
Phase 1/2 Recruiting
NCT05435495 2026-03-18
Mechanisms of Resistance to PSMA Radioligand Therapy
University of California, San Francisco
Recruiting
NCT05500391 2026-03-18
SUR-CAN
Centre Oscar Lambret
Phase 2 Recruiting
NCT05556642 2026-03-18
Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative
Children's Hospital Medical Center, Cincinnati
Recruiting
NCT05787834 2026-03-18
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer
Roswell Park Cancer Institute
Phase NA Recruiting
NCT05806931 2026-03-18
SCOTI
Rutgers, The State University of New Jersey
Phase 2 Recruiting
NCT05941741 2026-03-18
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
Sun Yat-sen University
Phase 3 Recruiting
NCT06071624 2026-03-18
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.
Indiana University
Phase 1 Recruiting
NCT06077591 2026-03-18
PDO
Chinese University of Hong Kong
Phase NA Recruiting